Phathom Pharmaceuticals, Inc. PHAT Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s interest coverage?
- Phathom Pharmaceuticals, Inc. (PHAT) reported interest coverage of -1.5× in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s interest coverage changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s interest coverage increased by 62.6% year-over-year, from -3.9× to -1.5×.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s interest coverage?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s interest coverage has grown at a -38.8% compound annual growth rate (CAGR), from -27.4× to -2.3×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.